TABLE 1.
Characteristics of H. influenzae isolates analyzed in the study
| Epa | Isolateb
|
Presencec of fragments with the following sizes (kb):
|
Sourced | Serotype | Biotype | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | No. | 2.11 | 1.75 | 1.5 | 1.25 | 1.1 | 0.97 | 0.84 | 0.72 | 0.65 | 0.59 | 0.51 | 0.45 | 0.43 | ||||
| 1 | In 30 | 1 | – | – | – | – | – | – | – | CSF | b | IV | ||||||
| In 19 | 14 | – | – | – | – | – | – | – | CSF1 | b | VI | |||||||
| In 29 | 23 | – | – | – | – | – | – | – | CSF2 | b | IV | |||||||
| Lc144 | 78 | – | – | – | – | – | – | – | CSF | b | VI | |||||||
| Lc175 | 79 | – | – | – | – | – | – | – | CSF2 | b | IV | |||||||
| 2 | In 8 | 6 | – | – | – | – | – | – | – | – | CSF | b | IV | |||||
| In 26 | 21 | – | – | – | – | – | – | – | – | CSF | b | IV | ||||||
| Gb392 | 80 | – | – | – | – | – | – | – | – | SAR | b | IV | ||||||
| Gb638 | 81 | – | – | – | – | – | – | – | – | BS | b | IV | ||||||
| 3 | In 10 | 8 | – | – | – | – | – | – | – | – | – | BS | NTe | II | ||||
| LC755 | 71 | – | – | – | – | – | – | – | – | – | CSF1 | b | VI | |||||
| LC849 | 72 | – | – | – | – | – | – | – | – | – | CSF | b | IV | |||||
| LC795 | 73 | – | – | – | – | – | – | – | – | – | CSF | b | IV | |||||
| 4 | In 18 | 13 | – | – | – | – | – | – | – | – | CSF1 | b | IV | |||||
| In 23 | 18 | – | – | – | – | – | – | – | – | CSF | b | VI | ||||||
| Le 8 | 53 | – | – | – | – | – | – | – | – | SAR | b | IV | ||||||
| Le 16 | 58 | – | – | – | – | – | – | – | – | CSF | b | IV | ||||||
| Gb567 | 83 | – | – | – | – | – | – | – | – | CSF | b | VI | ||||||
| Gb513 | 74 | – | – | – | – | – | – | – | – | CSF | b | VI | ||||||
| 5 | In 21 | 16 | – | – | – | – | – | – | – | – | – | CSF | b | IV | ||||
| In 27 | 22 | – | – | – | – | – | – | – | – | – | CSF2 | b | VI | |||||
| Le 1 | 45 | – | – | – | – | – | – | – | – | – | CSF | b | IV | |||||
| Le 2 | 46 | – | – | – | – | – | – | – | – | – | B S | NT | VI | |||||
| LC323 | 70 | – | – | – | – | – | – | – | – | – | CSF | b | VI | |||||
| 6 | In 9 | 7 | – | – | – | – | – | – | – | NF | NT | IV | ||||||
| 7 | Le34 | 69 | – | – | – | – | – | – | – | – | – | – | NF | NT | IV | |||
| 8 | Hinf | 29 | – | – | – | – | – | – | – | CSF | b | I | ||||||
| 9 | Hinf6 | 30 | – | – | – | – | – | – | – | – | CSF | b | VI | |||||
| 10 | Nez 6 | 85 | – | – | – | – | – | – | – | AC | NT | IV | ||||||
| 11 | 646 | 86 | – | – | – | – | – | – | – | – | CSF | b | IV | |||||
| 12 | In 7 | 5 | – | – | – | – | – | – | – | CSF | b | I | ||||||
| 13 | GO | 27 | – | – | – | – | – | – | – | BS | b | IV | ||||||
| 14 | LC132 | 26 | – | – | – | – | – | – | – | – | CSF | b | IV | |||||
| 15 | 140gb | 82 | – | – | – | – | – | – | – | CSF2 | b | IV | ||||||
| 16 | 08ii | 35 | – | – | – | – | – | – | – | AC | NT | IV | ||||||
| 17 | Le 19 | 61 | – | – | – | – | – | – | – | – | NF | NT | I | |||||
| 18 | In 22 | 17 | – | – | – | – | – | – | – | BS | b | II | ||||||
| 19 | Le 26 | 65 | – | – | – | – | – | – | BS | NT | V | |||||||
| 20 | Le 11 | 56 | – | – | – | – | – | – | SP | NT | IV | |||||||
| 21 | In 2 | 24 | – | – | – | – | – | – | – | – | – | SP | NT | IV | ||||
| 22 | Le 27 | 66 | – | – | – | – | – | – | – | – | – | GT | NT | VI | ||||
| 23 | Le 4 | 48 | – | – | – | – | – | – | – | CSF | b | VI | ||||||
| 24 | LC390 | 76 | – | – | – | – | – | – | CSF | b | IV | |||||||
| 25 | LC861 | 75 | – | – | – | – | – | – | – | – | – | CSF | b | IV | ||||
| 26 | In 3 | 2 | – | – | – | – | – | – | – | – | – | NF | NT | IV | ||||
| 27 | Le 18 | 60 | – | – | – | – | – | – | – | NF | NT | I | ||||||
| 28 | In 25 | 20 | – | – | – | – | – | – | – | – | – | – | BS | b | VI | |||
| 29 | LE 22 | 64 | – | – | – | – | – | – | – | – | ME | NT | IV | |||||
| 30 | In 6 | 4 | – | – | – | – | – | – | – | CSF | b | IV | ||||||
| 31 | 15II | 10 | – | – | – | – | – | – | – | – | AC | NT | I | |||||
| 32 | 39ii | 43 | – | – | – | – | – | – | AC | NT | I | |||||||
| 33 | Le 33 | 77 | – | – | – | – | – | NF | NT | II | ||||||||
| 34 | C7196 | 36 | – | – | – | – | – | – | – | – | BS | NT | III | |||||
| 35 | Le13 | 47 | – | – | – | – | – | – | BS | NT | IV | |||||||
| 36 | In 16 | 11 | – | – | – | – | – | – | – | – | CSF | b | II | |||||
| In 17 | 12 | – | – | – | – | – | – | – | – | BS | b | IV | ||||||
| In 32 | 25 | – | – | – | – | – | – | – | – | CSF | b | IV | ||||||
| 37 | In 20 | 15 | – | – | – | – | – | – | – | – | – | CSF | b | IV | ||||
| 38 | Le 6 | 50 | – | – | – | – | – | – | – | – | EY | NT | IV | |||||
| 39 | Le 20 | 62 | – | – | – | – | – | – | – | – | NF | b | II | |||||
| 40 | In 24 | 19 | – | – | – | – | – | – | – | – | – | – | CSF | b | I | |||
| 41 | Le 10 | 51 | – | – | – | – | – | – | – | – | BS | NT | IV | |||||
| 42 | Le 32 | 68 | – | – | – | – | – | – | – | ME | NT | I | ||||||
| 43 | In 5 | 3 | – | – | – | – | – | SP | NT | IV | ||||||||
| 44 | Le 17 | 59 | – | – | – | – | – | NF | b | V | ||||||||
| 45 | Le | 55 | – | – | – | – | – | CSF | b | I | ||||||||
| 46 | In 11 | 9 | – | – | – | – | – | BS | b | III | ||||||||
| 47 | UAM | 31 | – | – | – | – | CSF | b | I | |||||||||
| Le 7 | 32 | – | – | – | – | SAR | NT | IV | ||||||||||
| 48 | H2 | 28 | – | – | – | CSF | b | II | ||||||||||
| 49 | 13ii | 39 | – | – | – | – | – | AC | NT | V | ||||||||
| 50 | Le 5 | 49 | – | – | – | – | NF | NT | IV | |||||||||
| 51 | 06ii | 33 | – | – | – | – | AC | NT | VI | |||||||||
| 52 | 07ii | 34 | – | – | – | – | – | AC | NT | I | ||||||||
| 53 | Nez 8 | 84 | – | – | – | – | – | – | AC | NT | VI | |||||||
| 54 | 12ii | 38 | – | – | – | – | AC | NT | I | |||||||||
| 55 | 19ii | 41 | – | – | – | AC | NT | IV | ||||||||||
| 56 | Nez15 | 92 | – | – | – | – | AC | NT | IV | |||||||||
| 57 | Nez12 | 88 | – | – | – | – | – | AC | NT | IV | ||||||||
| 58 | Nez13 | 90 | – | – | – | AC | NT | IV | ||||||||||
| 59 | 14ii | 37 | – | – | – | – | AC | NT | IV | |||||||||
| In 12 | 40 | – | – | – | BS | b | IV | |||||||||||
| 60 | 49ii | 44 | – | – | – | AC | NT | IV | ||||||||||
| 61 | 01ii | 52 | – | – | – | – | AC | NT | IV | |||||||||
| 62 | 18ii | 42 | – | – | – | – | AC | NT | I | |||||||||
| 63 | Nez10 | 87 | – | – | AC | NT | IV | |||||||||||
| 64 | Le 9 | 54 | – | – | – | – | – | – | BS | NT | IV | |||||||
| 65 | Le 21 | 63 | – | – | – | – | – | – | NF | NT | I | |||||||
| 66 | Nez14 | 91 | – | – | – | – | AC | NT | IV | |||||||||
| 67 | Le 15 | 57 | – | – | – | – | – | – | – | – | BS | NT | III | |||||
| 68 | Nez11 | 89 | – | – | – | – | – | – | – | AC | NT | IV | ||||||
| 69 | Le 31 | 67 | – | – | – | – | – | ME | NT | V | ||||||||
a
Eps are arbitrarily numbered as per the phenogram in Fig. 1.
b
Clinical strains and strains from healthy child carriers shipped to our institution from the INDRE and HIM, SSA, Mexico City, Mexico. Isolates are numbered arbitrarily as in the phenogram.
c
–, fragment present.
d
CSF, (meningitis); SAR, supurative arthritis; BS, bronchial secretion; SP, sputum; NF, nasopharynx; GT, genital tract; ME, middle ear; EY, eye; AC, asymptomatic carrier; CSF1 and CSF2, CSF (meningitis) strains from the Mexican states of Michoacan and Morelos, respectively.